Compare AMRC & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMRC | RLAY |
|---|---|---|
| Founded | 2000 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Engineering & Construction | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.5B |
| IPO Year | 2010 | 2020 |
| Metric | AMRC | RLAY |
|---|---|---|
| Price | $30.67 | $8.13 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 7 |
| Target Price | ★ $33.22 | $16.00 |
| AVG Volume (30 Days) | 468.7K | ★ 2.3M |
| Earning Date | 11-03-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 18.87 | N/A |
| EPS | ★ 1.19 | N/A |
| Revenue | ★ $1,883,767,000.00 | $8,355,000.00 |
| Revenue This Year | $9.83 | $20.47 |
| Revenue Next Year | $9.83 | N/A |
| P/E Ratio | $24.61 | ★ N/A |
| Revenue Growth | ★ 12.22 | N/A |
| 52 Week Low | $8.49 | $1.78 |
| 52 Week High | $44.93 | $9.04 |
| Indicator | AMRC | RLAY |
|---|---|---|
| Relative Strength Index (RSI) | 46.11 | 53.65 |
| Support Level | $28.72 | $8.25 |
| Resistance Level | $30.90 | $8.58 |
| Average True Range (ATR) | 1.24 | 0.46 |
| MACD | 0.13 | -0.05 |
| Stochastic Oscillator | 58.50 | 33.46 |
Ameresco Inc provides energy efficiency solutions for facilities in North America and Europe. It focuses on projects that reduce energy, also focuses on the operations and maintenance costs of governmental, educational, utility, healthcare, and other institutional, commercial, and industrial entities facilities. Ameresco distributes solar energy products and systems, such as PV panels, solar regulators, solar charge controllers, inverters, solar-powered lighting systems, solar-powered water pumps, solar panel mounting hardware, and other system components. The company's segment includes U.S. Regions; U.S. Federal; Canada; Alternative Fuels; Non-Solar DG and All Other. It derives a majority of its revenue from the U.S. Regions segment.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).